SOURCE: Renato Corporation

September 15, 2008 13:19 ET

Renato Corporation Provides Investment to Pic-See's Ophthalmic Image Processing Technology

MIAMI, FL--(Marketwire - September 15, 2008) - Renato Corporation (FRANKFURT: 4OZ), a company providing advanced early detection diagnostic care via private clinics and health and wellness centers, has provided its initial capital investment in Pic-See Inc.'s patented digital image processing technology. Ophthalmic technology helps to quickly capture ultra high-resolution digital images that physicians can review, analyze, print and digitally communicate to medical personnel and technicians at any facility, anywhere in the world. To date, this is the only company that can process x-rays and utilize the internet as a delivery medium.

As the demand for integrated digital imaging and workflow management solutions continues to grow, Renato Corporation believes this new digital imaging technology will be applicable in other early detection technologies such as CT scanners, EBF body scans and MRIs. Renato expects to continue its financial support in these patented technologies to continually seek out the latest innovative early detection medical diagnostic devices. The company will ensure that non-invasive diagnostic technologies such as Thermography and Electronic Beam Tomography (EBT) body scanning will be made accessible and affordable to the general public. The remainder of the investment will be sent to Pic-See Inc. in the third week of September 2008.

www.renatocorp.com

About Renato Corporation

At Renato Corporation it is the company's objective to provide diverse early detection diagnostic technologies utilizing its current experience, reputation and expertise within the international health care industry. Introducing and making available these non-invasive technologies through private health care firms and health and wellness centers in an affordable manner is our immediate focus.

The company's mission is to carefully select where these advanced diagnostic technologies will be placed to ensure unparalleled delivery of customer service and satisfaction in the field of non-invasive early detection disease diagnosis and management.

Innovative information technology platforms are enabling new models for more efficient, effective and safer healthcare delivery. It is inevitable, that the economic strain on today's health care systems worldwide will realize the ever increasing need for early detection diagnostic devices and services.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are forward-looking statements are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties, or other factors which may cause actual results, performance, or achievements of the company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Actual results could differ materially because of factors such as the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels. All information in this release is as of the date of this release. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.

Contact Information

  • Contact:
    Arunas Morkunas
    Director
    Renato Corporation
    305-456-7649 head office
    416-572-2229 Canadian offices
    www.renatocorp.com